Plant cure for opioid addiction taking heat from the FDA: Claims of danger most likely linked to its impact on Big Pharma’s bottom line

(Natural News) Kratom, the popular plant-based opioid alternative from Southeast Asia, was the subject of an advisory from the Food and Drug Administration (FDA) on Tuesday, November 14, after the group called the substance “troubling” and blocked hundreds of kratom shipments to the U.S. In their statement, FDA Commissioner Scott Gottlieb reported that there are…

>View original article